英国NIBSC标准品_上海源迈生物科技有限公司-上海源迈生物科技有限公司

代理品牌

Jena Bioscience由德国马普所(MPI)的分子生理学家于1998年共同创办的生物公司，致力为全球的科研院所、医院、制药企业以及诊断试剂盒生产企业提供各类试剂。在结构学研究方面全面提供晶体筛选

tedpella是世界著名的电子显微镜及病理,光学显微镜相关试剂及耗材供应商

英国NIBSC标准品

NIBSC成立于2004 年，主要负责开发和生产超过90%的国际标准药品，该机构在WHO中具有领先地位。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的官方药品控制实验室(OMCL)。
英国NIBSC标准品(图1)

Product Number	Description
00/410	MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) International Reference Preparation
00/416	Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) International Reference Preparation
00/418	MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) International Standard
00/422	High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) International Reference Preparation
00/440	Influenza Antiserum A/Singapore/1/57 (H2) Influenza
00/442	Influenza anti B/Yamanashi/166/98 Serum Influenza
00/464	Streptokinase (3rd International Standard 2001) International Standard
00/498	Diphtheria Antitoxin Human IgG Working standard single unit sales
00/500	Botulinum Type A-E Antitoxin, Human Serum Non WHO Reference Material
00/530	Influenza Virus infectious B/Sichuan/379/99 Influenza
00/542	Influenza anti- A/Chick/Scotland/59 (H5N1) Serum Influenza
00/544	Influenza Virus infectious B/Victoria/504/00 Influenza
00/546	Influenza Antigen B/Johannesburg/5/99 Influenza
00/552	Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3) Influenza
00/556	Influenza anti-B/Johannesburg/5/99/ Serum Influenza
00/572	Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard) International Standard
00/574	Interferon Beta SER17 Mutein (Human, rDNA derived) Non WHO Reference Material
00/576	Interferon Beta (Human, Fibroblast-derived, Glycosylated) Non WHO Reference Material
007SP	Human Anti-Pneumococcal capsule Reference Serum (1st International Standard) International Standard
01/412	Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody Non WHO Reference Material
01/420	Interleukin-17 (Human rDNA derived)(International Reference Reagent) International Reference Reagent
01/424	Vascular Endothelial Growth Factor, Human rDNA derived Non WHO Reference Material
01/426	Meningococcal group Y polysaccharide Non WHO Reference Material
01/428	Meningococcal serogroup W polysaccharide Non WHO Reference Material
01/450	Influenza anti B/Guangdong/120/2000 Serum Influenza
01/452	Influenza anti A/Panama/2007/99 (H3N2) HA serum Influenza
01/506	Botulinum type F antitoxin, equine Non WHO Reference Material
01/508	Botulinum type C antitoxin, equine Non WHO Reference Material
01/510	Botulinum Antitoxin Equine Type D Non WHO Reference Material
01/512	Botulinum type G antitoxin, equine Non WHO Reference Material
01/514	Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody Non WHO Reference Material
01/528	Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules) International Reference Preparation
01/532	Oral PolioVaccine Sabin Type 3 Reference Strain International Reference Preparation
01/538	Anti-Meningococcal Serosubtype P1.16 mAb Non WHO Reference Material
01/546	Influenza Antigen B/Guangdong/120/2000 Influenza
01/580	Thrombin, human(2nd International Standard) International Standard
01/600	Anti-Toxoplasma IgG, Human(International Standard) International Standard
01/602	Anti-Parvovirus B19, plasma, human(2nd International Standard) International Standard
01/612	Influenza Virus infectious B/Hawaii/10/01 Influenza
01/614	Influenza Antigen A/New Caledonia/20/99 Influenza
02/102	Influenza anti A/Panama/2007/99 Serum Influenza
02/144	Anti-Meningococcal Serosubtype P1.15 mAb Non WHO Reference Material
02/148	Anti-Meningococcal Serosubtype P1.4 mAb Non WHO Reference Material
02/168	Prekallikrein Activator (PKA), Human(2nd International Standard) International Standard
02/178	Anti-Meningococcal Serosubtype P1.2 mAb Non WHO Reference Material
02/180	Anti-Meningococcal Serotype P2.2a mAb Non WHO Reference Material
02/182	Anti-Japanese Encephalitis Virus Plasma, Human Non WHO Reference Material
02/184	Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human Non WHO Reference Material
02/206	Factor XIII Plasma, Human (1st International Standard) International Standard
02/210	HIV (antibody), 1st International Reference Panel International Reference Preparation
02/226	IVIG negative control for use with IVIG + anti-D(International Reference Reagent) International Reference Reagent
02/228	IVIG + anti-D for use with negative control IVIG(International Reference Reagent) International Reference Reagent
02/230	Biotinylated Brad-5 (Bio-Brad-5) Working Standard
02/232	Tetanus Toxoid (Non-Adsorbed) Non WHO Reference Material
02/254	Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard) International Standard
02/262	Influenza Virus infectious B/Brisbane/32/2002 Influenza
02/286	Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent) International Reference Reagent
02/294	Influenza Antiserum A/chick/Italy/1347/99 (H7N1) Influenza
02/308	Anti-Meningococcal Serotype P3.4 mAb Non WHO Reference Material
02/310	Anti-Meningococcal Serotype P3.15 mAb Non WHO Reference Material
02/318	Botulinum Antitoxin Equine Type E Non WHO Reference Material
02/320	Anti-Meningococcal Serosubtype P1.3 mAb Non WHO Reference Material
02/336	Influenza Antigen A/New Caledonia/20/99 Influenza
02/338	Influenza anti A/Panama/2007/99 Serum Influenza
02/342	Protein C Plasma, Human(2nd International Standard) International Standard
03/104	HTLV-1 (antibody) Monitor Sample European Certification
03/110	Influenza anti B/Shangdong/9/97 Serum Influenza
03/114	Anti-Meningococcal Serosubtype P1.1 mAb Non WHO Reference Material
03/116	Blood Coagulation Factor V, Plasma Human (1st International Standard) International Standard
03/124	Thrombopoietin ( Human rDNA derived) Non WHO Reference Material
03/142	Anti-Meningococcal Serosubtype P1.14 mAb Non WHO Reference Material
03/148	Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent) International Reference Reagent
03/150	Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent) International Reference Reagent
03/152	Anti-HPA-1a (International Standard) International Standard
03/164	Anti-B minimum potency reference preparation(International Standard) International Standard
03/178	Vitamin B12, Serum Folate and holoTC (International standard) International Standard
03/182	Anti-Meningococcal Serotype P3.21 mAb Non WHO Reference Material
03/188	Anti-A minimum potency reference preparation(International Standard) International Standard
03/190	Anti-HPA-3a(minimum potency)(International Reference Reagent) International Reference Reagent
03/192	Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard) International Standard
03/198	Influenza Virus infectious A/Kumamoto/102/02 Influenza
03/200	Interleukin - 18 (Human rDNA derived)(International Reference Reagent) International Reference Reagent
03/210	Anti-Meningiococcal Serosubtype P1.6 mAb Non WHO Reference Material
03/212	Influenza anti A/Wyoming/03/03 Serum Influenza
03/220	Influenza Antigen A/Wyoming/03/03 Influenza
03/224	Anti-Meningococcal Serosubtype P1.10 mAb Non WHO Reference Material
03/226	Anti-Meningococcal Serosubtype P1.5 mAb Non WHO Reference Material
03/228	Protein S, Plasma, Human(2nd International Standard) International Standard
03/236	Anti-Meningococcal Serosubtype P1.13 mAb Non WHO Reference Material
03/242	Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum Influenza
03/244	Influenza Antiserum A/chick/Germany/N/49 Influenza
03/258	Influenza Antigen A/New Caledonia/20/99 (IVR-116) Influenza
03/262	Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel) International Reference Preparation
04/122	Anti-Meningococcal Serosubtype P1.12 mAb Non WHO Reference Material
04/140	IVIG Negative Control for use with IVIG & Anti-D Non WHO Reference Material
04/150	Tetanus Toxoid For Flocculation Test(2nd International Standard) International Standard
04/160	Influenza Virus infectious NYMC X-147 Influenza
04/166	TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent) International Standard
04/170	Influenza Virus infectious A/Wellington/1/2004 Influenza
04/172	Influenza Virus infectious IVR-139 Influenza
04/176	Plasmodium falciparum DNA for NAT Assays(1st International Standard) International Standard
04/198	Anti-Meningococcal Serotype P3.1 mAb Non WHO Reference Material
04/202	Influenza Antigen B/ Jiangsu/10/2003 Influenza
04/224	Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 International Standard
04/228	Influenza anti B/ Neuraminidase Serum Influenza
04/242	Influenza anti B/Jiangsu/10/2003 HA Serum Influenza
04/246	Anti-Meningococcal Serogroup W-135 mAb Non WHO Reference Material
04/248	Anti-Meningococcal Serosubtype P1.19 mAb Non WHO Reference Material
04/252	Protein C Concentrate, Human(1st International Standard) International Standard
04/260	Influenza anti A/New Caledonia/20/99 HA Serum Influenza
04/262	Influenza anti A/New York/55/2004 HA Serum Influenza
04/264	Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) Influenza
05/102	Influenza Virus infectious NYMC BX-7 Influenza
05/106	Anti-HPA-1a minimum potency reagent(2nd International Reference reagent) International Reference Reagent
05/110	Influenza Virus infectious A/California/7/2004 Influenza
05/112	Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). International Standard
05/122	Syphilitic plasma IgG (human)(1st International Standard) International Standard
05/130	Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005) International Standard
05/134	Anti-human papillomavirus type 16 serum (1st International Standard) International Standard
05/138	Influenza Virus infectious B/Shanghai/361/2002 Influenza
05/162	Alpha-1-Antitrypsin, plasma derived(1st International standard) International Standard
05/190	Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody Non WHO Reference Material
05/192	Anti Meningococcal Serotype P2.2b Monoclonal Antibody Non WHO Reference Material
05/234	Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142) Influenza
05/236	Influenza anti A/Wisconsin/67/2005 Serum Influenza
05/242	IVIG, Anti-D and Negative Control Panel Non WHO Reference Material
05/252	Influenza anti B Neuraminidase Serum Influenza
06/108	Influenza Virus infectious IVR-116 Influenza
06/124	Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard) International Standard
06/128	Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard) International Standard
06/140	Pertussis Antiserum(human)1st IS-WHO international Standard. International Standard
06/142	Pertussis Antiserum (Human) 1st WHO Reference Reagent International Reference Reagent
06/164	Influenza Virus infectious 1 VR-142 Influenza
06/166	Antithrombin Concentrate, Human (3rd International Standard) International Standard
06/170	Influenza Antigen A/New Caledonia/20/99 Influenza
06/192	Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466) Influenza
06/202	Human Papillomavirus (HPV) Type 16 DNA (1st International Standard) International Standard
06/206	Human Papillomavirus (HPV) Type 18 DNA (1st International Standard) International Standard
06/242	Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR) Influenza
07/102	Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145) Influenza
07/104	Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum Influenza
07/112	Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 Influenza
07/132	Influenza Virus infectious B/Malaysia/2506/2004 Influenza
07/144	Influenza Virus infectious IVR-145, Influenza
07/146	Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep) Influenza
07/148	Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum Influenza
07/150	Human Plasma Anti-Influenza H5N1 (1st International Standard) International Standard
07/164	Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard) International Standard
07/184	Influenza anti B/Malaysia/2506/2004-HA Serum Influenza
07/202	Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) International Reference Reagent
07/204	Influenza Virus Infectious NIBRG-60 VE2 25820 Influenza
07/214	Positive Control for use in flow cytometry cross matching (FCXM) European Certification
07/216	Diphtheria Toxoid (Adsorbed) (4th International Standard) International Standard
07/222	RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent) International Reference Reagent
07/226	Influenza Virus Infectious A/New Caledonia/20/99 Influenza
07/228	Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” International Standard
07/268	Influenza Virus Infectious B/Brisbane/3/2007 Influenza
07/270	BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) International Reference Reagent
07/272	BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) International Reference Reagent
07/274	BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) International Reference Reagent
07/278	Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475) Influenza
07/286	Monitor sample for HBsAg 0.05IU/ml European Certification
07/288	Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml European Certification
07/290	Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 Influenza
07/296	Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques Clinical Virology Network
07/298	Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques Clinical Virology Network
07/300	Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques Clinical Virology Network
07/304	Anti-D for assuring operator and test performance Working Standard
07/306	Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent) International Reference Reagent
07/316	Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) International Standard
07/318	Meningococcal Group C Polysaccharide Non WHO Reference Material
07/328	Unfractionated Heparin (6th I.S.) International Standard
07/336	Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60 Influenza
07/338	Influenza antiserum A/Anhui/1/05 (H5) Influenza
07/348	Influenza Virus infectious NYMC X-171B Influenza
07/350	Blood Coagulation Factor VIII Concentrate (8th I.S.) International Standard
07/358	Influenza Virus infectious NIB-50 Influenza
07/362	Influenza Virus infectious IVR-149 Influenza
07/364	Chorionic Gonadotrophin, (5th IS) International Standard
07/B498	QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 Quality Control Reagent
08/100	Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) Influenza
08/108	Influenza Virus Infectious NIBRG-91 Influenza
08/118	Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques Clinical Virology Network
08/120	Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques Clinical Virology Network
08/126	Influenza Anti N1 Neuraminidase Serum SH485 Influenza
08/138	Influenza Virus Infectious B/Florida/4/2006 Influenza
08/140	Influenza Antigen B/Florida/4/2006 Influenza
08/142	Influenza antiserum A/Anhui/1/05 (H5) Influenza
08/148	Positive control for Luminex based anti-HLA Class II serology European Certification
08/156	Influenza Virus Infectious NIBRG-23 30060 VE3 Influenza
08/158	Fragile X Syndrome gDNA (1st International Genetic Reference Panel) International Standard
08/160	Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel) International Standard
08/174	Human Coxsackie B4 for Nucleic Acid Amplification Techniques Clinical Virology Network
08/176	Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques Clinical Virology Network
08/178	Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques Clinical Virology Network
08/180	Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques Clinical Virology Network
08/184	Influenza Antigen B/Malaysia/2506/2004 Influenza
08/202	Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) Influenza
08/204	Thyroid Stimulating Antibody (2nd I.S.) International Standard
08/208	Influenza Antigen Hong Kong/1073/99 (H9N2) Influenza
08/210	Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) Influenza
08/214	Meningococcal Serogroup C polysaccharide (1st International Standard) International Standard
08/216	Influenza Antigen A/Cambodia/RO405050/2007 (H5N1) Influenza
08/218	Tetanus Toxoid Adsorbed (4th International Standard) International Standard
08/228	Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 Influenza

公司将产品的高质量作为最高标准，每一个产品都要通过严格的质量监测体系检测，确保了稳定可靠的产品。目标是提供卓越的产品和高效的技术支持，同时还努力开发更先进的检测系统，保证客户能得到代表最高水平的服务。

从研究与临床需要出发，设计开发产品，真正满足实际要求，产品已被生命科学研究群体所广泛认同；有完善的专业文献资料积累，所有产品都提供详细的技术资料与重要的相关文献；产品提供多种规格,可以适应各种不同要求，此外还可根据实验要求选择特定的产品形式或规格。作为可靠的供应商，公司始终如一地提供最高质量和具有竞争力的性价比的产品。我们对卓越和独特产品的热情超越了我们在市场上的良好声誉。赢得了无数客户的信赖，永不停止追求最高水平的客户满意度。

上海源迈生物致力为中国的科研工作者们提供更全面更优质的产品，快捷的到货速度，完善的售后服务，使您的工作如虎添翼让您的科研实验取得更加优越的成绩。欢迎下载下面的资料以了解此产品的相关信息！预询产品订购信息欢迎致电

上海源迈生物致力于提供最高质量的产品和服务组织形态学研究与竞争力的产品

产品和服务,有相关产品的问题请直接联系我们

期货每周下午5点前发定单，正常到上海时间为3-4周

现市区2天内送到，外地以快递为准

敬请关注！http://www.ymaibio.com

电话：15021674120 021-61525180

email:pumaibio@163.com

QQ:1941165944(终端）

QQ：1715039028（经销商）

最新促销Ablab、Eurogentec、Chemicell、BrainBits、Emsdiasum、Dyesol、Bangs Laboratories、Macrocyclics、Flystuff、EYlabs、scientific Commodities、Xcessbio Biosciences、omicronbio、A-M systems、Glycotech、Diagnostic Automation、AK Scientific、emfret ANALYTICS、LaysanBio、Peptides International、ademtech、Skyspring nanomaterials、Biosearchtech、Hematologic Technologies、ssnano、Neuvitro、immunochemistry techmologies、spherotech、Microspheres - Nanospheres、swant、Neuromab、Avanti、tedpella、Megazyme、teknova、Chem-Impex、Chondrex、List biological、Moltox、Xcessbio Biosciences、Instech、Osteomark、Mattek、NIBSC、Haematologic Technologies、Bangs Laboratories、GoldBio、Bio-Serv、Toxin Technology